The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Allakos Inc COM 01671P100 22,583 287,205 SH   SOLE   287,205 0 0
Aravive Inc COM 03890D108 3,320 442,733 SH   SOLE   442,733 0 0
Atreca Inc COM 04965G109 7,238 591,368 SH   SOLE   591,368 0 0
Catabasis Pharmaceuticals Inc COM 14875P206 1,620 300,000 SH   SOLE   300,000 0 0
Evelo Biosciences Inc COM 299734103 1,388 227,529 SH   SOLE   227,529 0 0
Gossamer Bio Inc COM 38341P102 6,323 376,583 SH   SOLE   376,583 0 0
Hookipa Pharma Inc COM 43906K100 3,977 530,245 SH   SOLE   530,245 0 0
Intercept Pharmaceuticals Inc COM 45845P108 26,789 403,688 SH   SOLE   403,688 0 0
KalVista Pharmaceuticals Inc COM 483497103 1,375 118,500 SH   SOLE   118,500 0 0
Liquidia Technologies Inc COM 53635D202 550 154,462 SH   SOLE   154,462 0 0
Millendo Therapeutics Inc COM 60040X103 1,326 186,540 SH   SOLE   186,540 0 0
Odonate Therapeutics Inc COM 676079106 13,604 522,637 SH   SOLE   522,637 0 0
Principia Biopharma Inc COM 74257L108 10,829 383,480 SH   SOLE   383,480 0 0
Springworks Therapeutics Inc COM 85205L107 14,669 676,602 SH   SOLE   676,602 0 0
Sunesis Pharmaceuticals Inc COM 867328700 2,599 3,610,913 SH   SOLE   3,610,913 0 0
Sutro BioPharma Inc COM 869367102 10,232 1,125,579 SH   SOLE   1,125,579 0 0
Syros Pharmaceuticals Inc COM 87184Q107 17,012 1,726,603 SH   SOLE   1,726,603 0 0
Urovant Sciences Ltd COM G9381B108 1,491 157,480 SH   SOLE   157,480 0 0